Difference between revisions of "User talk:Laner Verena/My sandbox"
From Bioblast
Laner Verena (talk | contribs) |
Laner Verena (talk | contribs) |
||
| Line 8: | Line 8: | ||
* OROBOROS INSTRUMENTS participates in two HORIZON 2020 funded Marie Skłodowska-Curie projects: | * OROBOROS INSTRUMENTS participates in two HORIZON 2020 funded Marie Skłodowska-Curie projects: | ||
:::* '''TRACT''' – '''Tra'''ining in '''C'''ancer mechanisms and '''T'''herapeutics: TRACT will enable eleven PhD Fellows to complete research projects in the three critical areas: biomarker discovery, molecular resistance mechanisms and metabolic transformation mechanisms. This will allow for the discovery of novel insights into the molecular and cellular basis of oral and oesophageal cancer and generate new diagnostic tools and therapeutics that will improve patient response and survival. | :::* '''TRACT''' – '''Tra'''ining in '''C'''ancer mechanisms and '''T'''herapeutics: TRACT will enable eleven PhD Fellows to complete research projects in the three critical areas: biomarker discovery, molecular resistance mechanisms and metabolic transformation mechanisms. This will allow for the discovery of novel insights into the molecular and cellular basis of oral and oesophageal cancer and generate new diagnostic tools and therapeutics that will improve patient response and survival. '''[[TRACT|More info? - Apply now!]]''' | ||
:::*'''TRANSMIT'''- Start in January 2017. | :::*'''TRANSMIT'''- Start in January 2017. '''[http://cordis.europa.eu/project/rcn/205395_en.html More info?]''' | ||
* Horizon 2020 '''COST Action CA15203 MITOEAGLE''' - official start 2016 Sep 12. | * Horizon 2020 '''COST Action CA15203 MITOEAGLE''' - official start 2016 Sep 12. '''[[COST_Action_MITOEAGLE| More info?]]''' | ||
Revision as of 13:13, 20 October 2016
- OROBOROS INSTRUMENTS participates in two HORIZON 2020 funded Marie Skłodowska-Curie projects:
- TRACT – Training in Cancer mechanisms and Therapeutics: TRACT will enable eleven PhD Fellows to complete research projects in the three critical areas: biomarker discovery, molecular resistance mechanisms and metabolic transformation mechanisms. This will allow for the discovery of novel insights into the molecular and cellular basis of oral and oesophageal cancer and generate new diagnostic tools and therapeutics that will improve patient response and survival. More info? - Apply now!
- TRANSMIT- Start in January 2017. More info?
- Horizon 2020 COST Action CA15203 MITOEAGLE - official start 2016 Sep 12. More info?
